GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Akebia Therapeutics AKBA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.53

+32.77%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Akebia Therapeutics

Our reporting

We have not reported on Akebia Therapeutics yet.

Next results

5 Nov 2026

Due on 5 Nov 2026. Analysts expect earnings of -0.04 a share on revenue of $46.9m.

Past results

Reported against what analysts expected

5 Aug 20267 May 202626 Feb 202610 Nov 20257 Aug 202513 Mar 2025
Earnings per share-0.02-0.03-0.050.000.00-0.10
Forecast-0.04-0.01-0.03-0.06-0.02-0.05
Revenue$49.1m$53.5m$57.6m$58.8m$62.5m$46.5m
Forecast$48.9m$51.7m$46.1m$48.4m$47.9m$37.4m

Key events

  1. 20 Mar 2014Listed

Akebia Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.